Latest News on DHC

Financial News Based On Company


Advertisement
Advertisement

What Just Happened With Diversified Healthcare Trust (DHC)?

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/what-just-happened-with-diversified-healthcare-trust-dhc
Diversified Healthcare Trust (DHC) recently released its third-quarter and nine-month results, reporting lower sales and revenue compared to the previous year, although the net loss significantly narrowed. The stock saw a 4.27% gain on the day of the announcement, trading at US$7.32, and has shown a year-to-date return of 46.99%. Simply Wall St's analysis suggests DHC is undervalued with a fair value of $10.15, noting that shrinking losses and ongoing capital recycling are positive signs, despite potential risks from rising interest costs or tenant vacancies.

211,155 Diversified Healthcare Trust $DHC Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al

https://www.marketbeat.com/instant-alerts/filing-211155-diversified-healthcare-trust-dhc-shares-sold-by-virginia-retirement-systems-et-al-2026-11-09/
VIRGINIA RETIREMENT SYSTEMS ET Al significantly reduced its stake in Diversified Healthcare Trust ($DHC), selling 211,155 shares and retaining only 11,200 shares. This comes as Diversified Healthcare Trust reported a quarterly loss that missed analyst expectations and declared a small quarterly dividend of $0.01 per share. Analysts currently have a "Moderate Buy" consensus rating for DHC with an average price target of $9.83.

Diversified Healthcare Trust (NASDAQ:DHC) Now Covered by Analysts at Freedom Broker

https://www.marketbeat.com/instant-alerts/analyst-diversified-healthcare-trust-nasdaq-dhc-now-covered-by-analysts-at-freedom-broker-2026-11-06/
Freedom Broker has initiated coverage on Diversified Healthcare Trust (NASDAQ:DHC) with a "strong-buy" rating, contributing to a "Moderate Buy" consensus and an average price target of $9.83 among analysts. Despite the positive coverage, DHC recently missed quarterly expectations, reporting a loss of $0.21 per share against an estimated loss of $0.15, and revenue of $367.67 million compared to a $370.87 million estimate. Institutional investors hold approximately 76% of the company's shares.

Diversified Healthcare Trust (DHC) Stock Dips Despite Strong Q3 Results

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/diversified-healthcare-trust-dhc-stock-dips-despite-strong-q
Diversified Healthcare Trust (DHC) reported strong Q3 2026 results, with normalized funds from operations at US$30.7 million and a 25.6% jump in same property cash net operating income. Despite these positive indicators, the stock dipped 2.5% to US$7.55, as traders focused on a headline earnings loss. The report highlights progress in senior housing operating performance and adjusted EBITDAre, suggesting an underlying improvement overshadowed by the reported loss.

Diversified Healthcare Trust Q3 Earnings Call Highlights

https://www.tradingview.com/news/marketbeat:f4bd1fdda094b:0-diversified-healthcare-trust-q3-earnings-call-highlights/
Diversified Healthcare Trust (DHC) reported strong third-quarter results, driven primarily by its senior housing operating portfolio (SHOP), which saw a 50.4% increase in same-property NOI. The company adjusted its non-GAAP measures to include accrued incentive management fees and raised its 2026 SHOP same-property NOI guidance. DHC also outlined strategic portfolio actions, including transitioning skilled nursing facilities and evaluating property dispositions, while reducing capital expenditure expectations.
Advertisement

Diversified Healthcare Trust Q3 2026 Earnings Call Is Live

https://www.tradingview.com/news/urn:live_audio:quartr.com:722927:0-diversified-healthcare-trust-q3-2026-earnings-call-is-live/
Diversified Healthcare Trust's (DHC) quarterly earnings call has just started, where executives will discuss the latest financial results and answer questions from analysts. This call is an opportunity for those following DHC to hear management's explanation of the numbers and potentially receive new information, as management commentary can significantly influence market reactions.

Diversified Healthcare Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/11/62826946/diversified-healthcare-q3-2026-earnings-call-transcript
Diversified Healthcare Trust reported strong third-quarter 2026 results, with normalized FFO of $30.7 million and Adjusted EBITDAre up 28.4% year-over-year. The company saw significant growth in its SHOP segment's NOI, driven by increased occupancy and average monthly rates, and is executing a strategic shift by transitioning seven skilled nursing facilities to a triple-net lease structure with The Ensign Group. DHC also raised its SHOP NOI guidance for 2026 and announced plans to optimize its portfolio through asset sales and targeted capital investments.

Diversified Healthcare Trust (NASDAQ:DHC) Shares Gap Down on Disappointing Earnings

https://www.marketbeat.com/instant-alerts/price-diversified-healthcare-trust-nasdaq-dhc-shares-gap-down-on-disappointing-earnings-2026-11-03/
Diversified Healthcare Trust (NASDAQ:DHC) shares experienced a significant gap down following a weaker-than-expected earnings announcement. The real estate investment trust reported an EPS of ($0.21), missing the consensus estimate of ($0.15), and revenue of $367.67 million, falling short of analysts' $370.87 million projection. Despite a "Moderate Buy" consensus rating from analysts, the disappointing financial results led to a drop in the stock price.

Diversified Healthcare Trust reports Q3 FFO 11c vs. (2c) last year

https://www.tipranks.com/news/the-fly/diversified-healthcare-trust-reports-q3-ffo-11c-vs-2c-last-year-thefly-news
Diversified Healthcare Trust (DHC) reported strong Q3 results, with FFO increasing to $0.11 per share compared to $(0.02) last year, and revenue of $367.7 million. The company's strategic initiatives led to a 25.6% increase in same property cash basis NOI and a 28.4% rise in Adjusted EBITDAre. The SHOP segment saw significant improvements in occupancy and average monthly rates, alongside the completion of a 15-year triple net lease for skilled nursing facilities and robust leasing activity in its Medical Office and Life Science portfolio.

How Investors May Respond To Diversified Healthcare Trust (DHC) Updated 2026 Guidance

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/how-investors-may-respond-to-diversified-healthcare-trust-dh-1
Diversified Healthcare Trust (DHC) recently released its Q3 2026 results and updated its full-year 2026 guidance, prompting investors to reassess the company's senior housing, medical office, and life science segments. Analysts project a significant turnaround for DHC by 2029, expecting revenue of US$1.7 billion and earnings of US$132.3 million, a considerable shift from its current loss-making position. The investment narrative largely hinges on the company's ability to execute on senior housing margin expansion and maintain stability in its other property segments to achieve profitability.
Advertisement

Revenue falls to $367.7M as Diversified Healthcare Trust (DHC) narrows its Q3 loss.

https://www.stocktitan.net/sec-filings/DHC/8-k-diversified-healthcare-trust-reports-material-event-bc7900e16a7b.html
Diversified Healthcare Trust (DHC) reported a narrowed Q3 2026 net loss of $50.2 million on revenues of $367.7 million, compared to a $164.0 million net loss on $388.7 million revenue a year prior. Key improvements include a 28.4% increase in Adjusted EBITDAre to $73.4 million and a rise in Normalized FFO per share to $0.13 from $0.02. The company also updated its full-year 2026 guidance and transitioned seven skilled nursing facilities to a new 15-year triple-net lease, expected to reduce future capital expenditures.

Diversified Healthcare Trust (DHC) Misses Q3 EPS by 6c

https://www.streetinsider.com/Earnings/Diversified+Healthcare+Trust+%28DHC%29+Misses+Q3+EPS+by+6c/27274448.html
Diversified Healthcare Trust (DHC) announced its Q3 earnings, reporting an EPS of ($0.21), which was $0.06 worse than the analyst estimate of ($0.15). The company's revenue for the quarter was $367.67 million, falling short of the consensus estimate of $370.87 million.

Diversified Healthcare Trust Revenue Falls 5.4% as Net Loss Narrows

https://www.tokenpost.com/news/business/47134
Diversified Healthcare Trust (DHC) reported a 5.4% year-over-year revenue decrease in Q3 2026, reaching $367.67 million, though its net loss significantly narrowed to $50.23 million from $164.04 million in the prior year. The trust announced a Normalized FFO of $0.13 per share and updated its full-year 2026 guidance to $0.46-$0.52 per share, reflecting stronger property-level performance.

DIVERSIFIED HEALTHCARE TRUST 6.25% SR NT 01/02/46 USD To Go Ex-Dividend On November 13th, 2026 With 0.39063 USD Dividend Per Share

https://www.moomoo.com/news/post/1002562173/diversified-healthcare-trust-6-25-sr-nt-01-02-46
Diversified Healthcare Trust (NASDAQ: DHC) 6.25% SR NT 01/02/46 USD is set to go ex-dividend on November 13th, 2026. The company will pay a dividend of 0.39063 USD per share.

What Investors Overlooked Before Diversified Healthcare Trust's 87% Run

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/what-investors-overlooked-before-diversified-healthcare-trus
Diversified Healthcare Trust (DHC) saw an 87.1% return for shareholders over the past year, driven by a shift towards more stable operations despite a revenue slip. Initially, investors weighed bullish prospects like aging demographics against bearish concerns of heavy debt. The company's recent 15-year triple net lease with Ensign Group for skilled nursing assets supported the bullish case for stable cash flows, shifting operating risk to the tenant.
Advertisement

Diversified Healthcare Trust (US25525P1075.SG) interactive stock chart

https://uk.finance.yahoo.com/quote/US25525P1075.SG/chart/
This page provides an interactive stock chart for Diversified Healthcare Trust (US25525P1075.SG) on Yahoo Finance, displaying its current trading price, percentage change, and options for historical data viewing. It also lists recent news and press releases related to the company, including dividend announcements, conference call schedules, and lease agreements. The page includes general market data and related tickers.

Diversified Healthcare Trust (US25525P1075.SG) analyst ratings, estimates and forecasts

https://uk.finance.yahoo.com/quote/US25525P1075.SG/analysis/
This Yahoo Finance page provides analyst ratings, estimates, and forecasts for Diversified Healthcare Trust (US25525P1075.SG). The current data shows no specific growth estimates available for the current quarter, next quarter, current year, or next year for the company or for the S&P 500. The stock is currently trading at 6.74 EUR, down 0.68%.

DIVERSIFIED HEALTHCARE TRUST 5.625% SR NT 01/08/2042 To Go Ex-Dividend On October 15th, 2026 With 0.35156 USD Dividend Per Share

https://www.moomoo.com/news/post/1001094070/diversified-healthcare-trust-5-625-sr-nt-01-08-2042
DIVERSIFIED HEALTHCARE TRUST 5.625% SR NT 01/08/2042 is scheduled to go ex-dividend on October 15th, 2026. The dividend per share will be 0.35156 USD. Investors should note this date for their dividend expectations.

Did New Nursing Home Lease Just Shift Diversified Healthcare Trust's (DHC) Investment Narrative?

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/did-new-nursing-home-lease-just-shift-diversified-healthcare
Diversified Healthcare Trust (DHC) has entered a new 15-year triple net lease for seven skilled nursing facilities, shifting their risk profile from a RIDEA structure to one with CPI-linked rent escalators. This move provides more predictable income and aligns with management's strategy to reposition the portfolio and reduce leverage, although concerns about balance sheet risk and refinancing remain. The lease is seen as a positive step for income visibility but doesn't fully address DHC's debt pressures or tenant concentration.

Third-quarter results are scheduled for release after the market closes Nov. 2; the call follows Nov. 3.

https://www.stocktitan.net/news/RMR/diversified-healthcare-trust-third-quarter-2026-conference-call-v547bhf0ikvc.html
Diversified Healthcare Trust (DHC) announced its third-quarter 2026 financial results will be released after the market closes on November 2, 2026. A conference call will be hosted by President and CEO Chris Bilotto and CFO Matthew Brown on November 3, 2026, at 10:00 a.m. Eastern Time to discuss these results. Details for accessing the call and a replay are provided for interested participants.
Advertisement

Diversified Healthcare Trust (DHC) grants CFO 53,050 shares

https://www.stocktitan.net/sec-filings/DHC/form-4-diversified-healthcare-trust-insider-trading-activity-7bd3adcbed02.html
Diversified Healthcare Trust (DHC) announced that its Chief Financial Officer and Treasurer, Matthew C. Brown, received an equity award of 53,050 Common Shares of Beneficial Interest on September 10, 2026. This grant was part of the company's equity compensation plan, increasing his direct holdings to 167,004 shares. The transaction was reported in a Form 4 filing to the SEC and is not related to a Rule 10b5-1 trading plan.

Public Employees Retirement System of Ohio Makes New Investment in Diversified Healthcare Trust $DHC

https://www.marketbeat.com/instant-alerts/filing-public-employees-retirement-system-of-ohio-makes-new-investment-in-diversified-healthcare-trust-dhc-2026-09-06/
The Public Employees Retirement System of Ohio has acquired a new stake in Diversified Healthcare Trust (NASDAQ:DHC), purchasing 257,877 shares valued at $2.4 million. This investment gives the Ohio retirement system a 0.11% ownership stake, contributing to the 75.98% of the REIT's stock held by institutional investors. Despite missing analyst estimates for its recent quarterly earnings, Diversified Healthcare Trust maintains a "Moderate Buy" consensus rating among analysts with an average price target of $9.83.

DHCNI | Diversified Healthcare Trust 5.625% Insider Trading

https://www.quiverquant.com/stock/DHCNI/insiders/
This article provides an overview of Diversified Healthcare Trust 5.625% Senior Notes due 2042 (DHCNI) focusing on various financial and ownership data points. It covers aspects like insider trading, institutional holdings, corporate lobbying, and analyst ratings, noting that there is no recent insider trading or congressional trading data for this ticker. The page also features an explanation of various financial metrics and offers premium access for more detailed insights.

Diversified Healthcare Trust rated 'Buy' with strong Q2 growth and improved balance sheet.

https://pluang.com/en/news-feed/diversified-healthcare-trust-rekomendasi-beli-waspada
Diversified Healthcare Trust (DHC) has received a 'Buy' rating due to its improved financial health and stronger balance sheet. In Q2 2026, the company saw significant growth in its SHOP segment's net operating income and a substantial increase in normalized funds from operations. DHC has also reduced its leverage, prioritizing balance sheet strength, and is viewed as an attractive investment opportunity due to ongoing growth in the SHOP segment and a favorable supply-demand environment.

Price to earnings forward of Diversified Healthcare Trust – NASDAQ:DHC

https://www.tradingview.com/symbols/NASDAQ-DHC/financials-statistics-and-ratios/price-earnings-fwd/
This article provides the "Price to earnings forward" value for Diversified Healthcare Trust (NASDAQ: DHC). It lists the company on the Nasdaq Stock Market and notes that the market was closed at the time of the data display. The content appears to be a financial data snippet from TradingView.
Advertisement

Diversified Healthcare Trust (NasdaqGS:DHC) Stock Forecast & Analyst Predictions

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/future
Diversified Healthcare Trust (DHC) is forecast to grow earnings by 48.5% and revenue by 4.8% annually, despite remaining unprofitable over the next three years. Analyst price targets have seen various adjustments, reflecting both improvements in its SHOP portfolio and ongoing concerns about its financial health, including debt and cash flow. The company has announced regular quarterly dividends of $0.01 per share.

Diversified Healthcare Trust $DHC Shares Bought by Bank of America Corp DE

https://www.marketbeat.com/instant-alerts/filing-diversified-healthcare-trust-dhc-shares-bought-by-bank-of-america-corp-de-2026-08-20/
Bank of America Corp DE significantly increased its stake in Diversified Healthcare Trust (NASDAQ:DHC) by 90.4% during the first quarter, now owning 2.68 million shares valued at $17.81 million. Other institutional investors and hedge funds, including Vanguard Group Inc., Carronade Capital Management LP, Charles Schwab Investment Management Inc., Goldman Sachs Group Inc., and Centersquare Investment Management LLC, also modified their holdings, reflecting broad institutional interest in the real estate investment trust. Analysts have issued a "Moderate Buy" consensus rating with a target price of $9.83 for DHC.

Diversified Healthcare Trust (DHC) Narrows Loss As Fair Value Narrative Stays Higher

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/diversified-healthcare-trust-dhc-narrows-loss-as-fair-value
Diversified Healthcare Trust (DHC) recently reported a narrowed net loss in its Q2 2026 results, despite lower revenue year-over-year. The company's share price has seen significant growth over the past year, though it experienced a slight pullback in the last month. The current market narrative suggests DHC is 15.1% undervalued, with a fair value estimate of $9.88, driven by strategic repositioning and asset sales.

Improved Losses Amid Weaker Revenue Might Change The Case For Investing In Diversified Healthcare Trust (DHC)

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/improved-losses-amid-weaker-revenue-might-change-the-case-fo
Diversified Healthcare Trust (DHC) recently reported Q2 2026 results showing improved losses despite weaker revenue, with sales at US$47.47 million and a net loss of US$37.42 million. While the reduced net loss suggests effective expense control, the company's investment narrative still hinges on managing high leverage and refinancing risks. Analysts continue to assess DHC's long-term profitability and fair value, with a modest dividend payout maintained to balance shareholder returns and debt management.

Improved Losses Amid Weaker Revenue Might Change The Case For Investing In Diversified Healthcare Trust (DHC)

https://www.sahmcapital.com/news/content/improved-losses-amid-weaker-revenue-might-change-the-case-for-investing-in-diversified-healthcare-trust-dhc-2026-08-11
Diversified Healthcare Trust (DHC) reported improved second-quarter 2026 results with reduced net losses and loss per share despite lower sales and revenue. While the trust's elevated leverage remains a risk, the contained dividend and operational adjustments suggest management is balancing shareholder returns with cash preservation. Analysts anticipate continued unprofitability but see potential upside, with some fair value estimates suggesting the stock could be worth over double its current price.
Advertisement

Diversified Healthcare Trust (NASDAQ:DHC) Given Consensus Recommendation of "Moderate Buy" by Analysts

https://www.marketbeat.com/instant-alerts/diversified-healthcare-trust-nasdaqdhc-given-consensus-recommendation-of-moderate-buy-by-analysts-2026-08-10/
Diversified Healthcare Trust (DHC) has received a "Moderate Buy" consensus rating from six analysts, with an average 12-month price target of $9.83. Institutional ownership stands at approximately 75.98%, with significant increases from Bank of America and a new position from Bank of New York Mellon. The company recently reported quarterly revenue of $365.39 million and an adjusted loss of $0.16 per share, and declared a quarterly dividend of $0.01 per share.

Amundi Makes New $847,000 Investment in Diversified Healthcare Trust $DHC

https://www.marketbeat.com/instant-alerts/filing-amundi-makes-new-847000-investment-in-diversified-healthcare-trust-dhc-2026-08-10/
Amundi has made a new investment of $847,000 in Diversified Healthcare Trust (DHC) by purchasing 127,594 shares, giving it a 0.05% stake in the company. Other institutional investors have also adjusted their holdings in DHC, which reported slightly missed quarterly earnings expectations and declared a $0.01 per share dividend. Analyst sentiment is moderately bullish, with a consensus price target of $9.83.

Dimensional Fund Advisors LP Purchases 138,708 Shares of Diversified Healthcare Trust $DHC

https://www.marketbeat.com/instant-alerts/filing-dimensional-fund-advisors-lp-purchases-138708-shares-of-diversified-healthcare-trust-dhc-2026-08-08/
Dimensional Fund Advisors LP increased its stake in Diversified Healthcare Trust (DHC) by 6.1%, purchasing an additional 138,708 shares to now own 2.4 million shares, or 0.99% of the REIT. Institutional investors collectively own 75.98% of DHC, which currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $9.83. Despite missing recent quarterly EPS and revenue estimates, the company declared a quarterly dividend of $0.01 per share.

DIVERSIFIED HEALTHCARE TRUST 6.25% SR NT 01/02/46 USD To Go Ex-Dividend On August 14th, 2026 With 0.39063 USD Dividend Per Share

https://news.futunn.com/en/post/77123535/diversified-healthcare-trust-6-25-sr-nt-01-02-46
Diversified Healthcare Trust (NASDAQ: DHC) 6.25% SR NT 01/02/46 USD is scheduled to go ex-dividend on August 14th, 2026. The dividend payment will be 0.39063 USD per share. This information is crucial for investors tracking dividend distributions for this security.

Is Diversified Healthcare Trust (DHC) Fairly Valued After Second Quarter Earnings?

https://www.sahmcapital.com/news/content/is-diversified-healthcare-trust-dhc-fairly-valued-after-second-quarter-earnings-2026-08-06
Diversified Healthcare Trust (DHC) stock gained significant momentum after reporting strong second-quarter 2026 results, with an 83.94% year-to-date return. Despite this, Simply Wall St's analysis suggests DHC is undervalued at $9.16, with a fair value estimate of $9.88 per share, based on expected cash flow from senior housing and medical office operations. However, investors should consider risks such as high leverage and reliance on asset sales.
Advertisement

Is Diversified Healthcare Trust (DHC) Fairly Valued After Second Quarter Earnings?

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/is-diversified-healthcare-trust-dhc-fairly-valued-after-seco
Diversified Healthcare Trust (DHC) is currently valued at $9.16 per share, showing strong year-to-date and one-year returns. Despite this momentum, the company is considered undervalued with a fair value estimate of $9.88 per share, based on its senior housing and medical office operations. Investors should also consider risks such as high leverage and reliance on asset sales.

Is Diversified Healthcare Trust (DHC) Fairly Valued After Second Quarter Earnings?

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/is-diversified-healthcare-trust-dhc-fairly-valued-after-seco/amp
Diversified Healthcare Trust (DHC) is in focus after its Q2 2026 earnings report, showing strong share price momentum and improved net loss figures. Despite this, the stock is considered 7.2% undervalued with a fair value of $9.88 per share, based on expected cash flow from its senior housing and medical office operations. However, investors should consider risks like high leverage and reliance on asset sales before making investment decisions.

How Investors Are Reacting To Diversified Healthcare Trust (DHC) Narrowing Losses Amid Softer Revenue

https://www.sahmcapital.com/news/content/how-investors-are-reacting-to-diversified-healthcare-trust-dhc-narrowing-losses-amid-softer-revenue-2026-08-04
Diversified Healthcare Trust (DHC) reported narrower losses in Q2 2026 despite softer revenue, with a net loss of US$37.42 million. The company maintained its quarterly dividend, signaling management's intent to return value to shareholders while facing ongoing challenges like high leverage and refinancing risk. Analysts have varying revenue and earnings forecasts for DHC, with some projecting a significant upside to its current price based on its fair value.

Diversified Healthcare Trust Encounters Operational ‘Noise’ in Ongoing Portfolio Transitions

https://seniorhousingnews.com/2026/08/04/diversified-healthcare-trust-encounters-operational-noise-in-ongoing-portfolio-transitions/
Diversified Healthcare Trust (DHC) reported lower-than-expected occupancy and revenue in Q2 2026, which CEO Chris Bilotto attributed to "transition noise" from switching operators for 116 communities. Despite this, the company saw sequential occupancy gains and increased NOI margins, reaffirming its SHOP NOI guidance for the year while revising occupancy and total revenue growth guidance downward. Bilotto expressed optimism for future occupancy improvements and noted an increase in revenue per occupied room (RevPOR).

Earnings call transcript: Diversified Healthcare Trust posts Q2 2026 miss but lifts outlook

https://www.investing.com/news/transcripts/earnings-call-transcript-diversified-healthcare-trust-posts-q2-2026-miss-but-lifts-outlook-93CH-4835018
Diversified Healthcare Trust (DHC) reported a Q2 2026 loss of $0.16 per share on revenue of $365.39 million, missing analyst expectations. Despite the miss, the company reaffirmed its full-year guidance, driven by strong operating trends, particularly in its senior housing operating properties (SHOP) segment, with same-property NOI rising 20.2%. Management highlighted improved occupancy, pricing power, and reduced leverage, indicating confidence in continued organic growth and potential future dividend reviews.
Advertisement

Diversified Healthcare Trust Q2 Profit Jumps 20% on Senior Housing Strength, Leverage Drops

https://finance.biggo.com/news/6636e6c2-a890-4151-af1d-c8d5664ddca6
Diversified Healthcare Trust (DHC) reported strong Q2 results, with consolidated NOI up 20.4% year over year, driven by a significant jump in senior housing operating portfolio (SHOP) NOI and improved occupancy and rates. The company reaffirmed its 2026 guidance for adjusted EBITDARE and normalized FFO, and saw its net debt to adjusted EBITDARE decrease. Although occupancy growth is slightly below expectations due to delays at transitioned communities, management anticipates benefits from renegotiated operator agreements and new redevelopment projects.

How Investors Are Reacting To Diversified Healthcare Trust (DHC) Narrowing Losses Amid Softer Revenue

https://simplywall.st/stocks/us/real-estate/nasdaq-dhc/diversified-healthcare-trust/news/how-investors-are-reacting-to-diversified-healthcare-trust-d
Diversified Healthcare Trust (DHC) reported narrower losses in Q2 2026, with a net loss of US$37.42 million despite softer revenue. While this shows progress in reducing financial damage, the company still faces ongoing revenue pressure and high leverage, making refinancing risk a key concern for investors. The reaffirmation of a modest quarterly dividend signals management's intent to maintain shareholder returns amidst these challenges.

Diversified Healthcare (DHC) Q2 FFO Top Estimates

https://finance.yahoo.com/healthcare/articles/diversified-healthcare-dhc-q2-ffo-224506954.html
Diversified Healthcare Trust (DHC) reported second-quarter Funds From Operations (FFO) of $0.16 per share, surpassing the Zacks Consensus Estimate of $0.14 per share and significantly higher than $0.08 per share a year ago. Despite missing revenue estimates, the company's FFO surprise was +14.29%, and its stock has seen an impressive 83.5% gain year-to-date. The stock currently holds a Zacks Rank #2 (Buy), indicating expected outperformance in the near future.

Earnings Flash (DHC) Diversified Healthcare Trust Posts Q2 Normalized FFO $0.16, vs. FactSet Est of $0.15

https://www.marketscreener.com/news/earnings-flash-dhc-diversified-healthcare-trust-posts-q2-normalized-ffo-0-16-vs-factset-est-of-ce7f50d9df8df52c
Diversified Healthcare Trust (DHC) announced its Q2 Normalized Funds From Operations (FFO) reached $0.16 per share, surpassing FactSet's estimate of $0.15. Despite this, the company's Q2 revenue fell to $365.4 million, missing FactSet's estimate of $370.8 million. DHC also provided guidance for 2026, expecting Normalized FFO per share to range between $0.56 and $0.62, compared to FactSet's estimate of $0.59.

Earnings Flash (DHC) Diversified Healthcare Trust Posts Q2 Revenue $365.4 Million, vs. FactSet Est of $370.8 Million

https://www.marketscreener.com/news/earnings-flash-dhc-diversified-healthcare-trust-posts-q2-revenue-365-4-million-vs-factset-est-o-ce7f50d9df8df52d
Diversified Healthcare Trust (DHC) reported its second-quarter revenue as $365.4 million, falling short of FactSet's estimate of $370.8 million. This earnings flash provides key financial data for the quarter, highlighting a slight miss on revenue expectations. The article also lists recent news and analyst ratings for DHC.
Advertisement

Diversified Healthcare Trust Announces Second Quarter 2026 Results

https://finviz.com/news/376328/diversified-healthcare-trust-announces-second-quarter-2026-results
Diversified Healthcare Trust (DHC) announced its financial results for the second quarter ended June 30, 2026, and provided updated full-year 2026 financial guidance. The company will host a conference call on August 4, 2026, to discuss these results. DHC is a real estate investment trust focused on healthcare properties, managed by The RMR Group.

Diversified Healthcare Trust (Nasdaq: DHC) reports Q2 2026 FFO up 109%

https://www.stocktitan.net/sec-filings/DHC/8-k-diversified-healthcare-trust-reports-material-event-3a1a0b79f24e.html
Diversified Healthcare Trust (DHC) reported strong Q2 2026 financial results, with Normalized FFO increasing by 109.4% year-over-year to $38.9 million. The company saw significant improvements in its senior housing operating portfolio, with same property SHOP NOI growing 37.2%, and its Medical Office and Life Science portfolio maintaining high occupancy and successful leasing activity. DHC reaffirmed its full-year 2026 guidance and declared a quarterly common distribution of $0.01 per share.

Diversified Healthcare earnings on deck after guidance raise

https://m.investing.com/news/earnings/diversified-healthcare-earnings-on-deck-after-guidance-raise-93CH-4831694?ampMode=1
Diversified Healthcare Trust is set to report its Q2 results, with analysts expecting a loss of $0.14 per share on $367.6 million in revenue, an improvement from the previous quarter. Investors will be looking to see if the company can deliver on its raised full-year guidance, which was boosted by anticipated cost savings and improvements in its senior housing portfolio. The focus will be on operational improvements, progress on operator transitions, and balance sheet management.

Arrowstreet Capital Limited Partnership Has $15.64 Million Stock Position in Diversified Healthcare Trust $DHC

https://www.marketbeat.com/instant-alerts/filing-arrowstreet-capital-limited-partnership-has-1564-million-stock-position-in-diversified-healthcare-trust-dhc-2026-07-31/
Arrowstreet Capital Limited Partnership increased its stake in Diversified Healthcare Trust (DHC) by 30.7% in the first quarter, now holding over 2.3 million shares valued at $15.64 million. Other hedge funds have also adjusted their positions in DHC, with institutional investors owning 75.98% of the stock. The company recently reported its quarterly earnings, missing analyst estimates, and announced a quarterly dividend of $0.01 per share.

RBF Capital LLC Decreases Stake in Diversified Healthcare Trust $DHC

https://www.marketbeat.com/instant-alerts/filing-rbf-capital-llc-decreases-stake-in-diversified-healthcare-trust-dhc-2026-07-30/
RBF Capital LLC reduced its stake in Diversified Healthcare Trust (DHC) by 15.5% in the first quarter, selling 177,475 shares and retaining 966,829 shares valued at $6.42 million. Diversified Healthcare Trust's stock has an average rating of "Moderate Buy" from analysts, with an average target price of $9.83. The company, a real estate investment trust specializing in healthcare properties, reported a quarterly loss and issued a quarterly dividend of $0.01 per share.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement